 prevent deep vein thrombosi elect hip surgeri random trial low molecular weight heparin standard unfraction heparin object rel efficaci safeti low molecular weight lmw heparin enoxaparin standard calcium heparin prevent postop deep vein thrombosi patient elect hip surgeri design double-blind trial patient sixty-f consecut patient hip replac hospit intervent patient fixed-dos lmw heparin mg fixed-dos standard calcium heparin unit regimen hour surgeri day discharg sooner measur patient postop leg scan imped plethysmographi result test posit venographi otherwis venographi day day patient readi discharg result evalu venogram patient lmw heparin patient calcium heparin patient evalu venogram thrombosi patient lmw heparin patient standard heparin differ CI proxim deep vein thrombosi patient lmw heparin patient standard heparin differ CI entir group patient venou thrombosi lmw heparin standard heparin hemorrhag complic patient standard heparin patient lmw heparin differ CI rel risk reduct rate major bleed standard heparin group lmw heparin group differ CI rel risk reduct conclus low molecular weight heparin hemorrhag unfraction heparin differ rate deep vein thrombosi signific use lmw heparin